Ma Yarui について
State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
He Siyuan について
State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Gao Aiai について
Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, Beijing, China について
Zhang Ying について
State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Zhu Qing について
State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Wang Pei について
State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Yang Beibei について
State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Yin Huihui について
State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Li Yifei について
State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Song Jinge について
State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Yue Pinli について
State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Zhang Dandan について
MOE Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences and Zhongshan Hospital, Fudan University, Shanghai, China について
Liu Yun について
MOE Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences and Zhongshan Hospital, Fudan University, Shanghai, China について
Wang Xiaobing について
State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Guo Mingzhou について
Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, Beijing, China について
Jiao Yuchen について
State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China について
Clinical Epigenetics (Web) について
メチル化 について
腫瘍 について
発癌 について
亜硫酸水素塩 について
食道 について
細胞周期 について
プロモーター領域 について
DNAメチルトランスフェラーゼ について
治療計画 について
TGFβ について
免疫組織化学 について
遺伝子サイレンシング について
食道扁平上皮癌 について
アゴニスト について
過剰発現 について
食道扁平上皮癌 について
全ゲノム亜硫酸水素配列決定 について
TGF BR2 について
メチル化の変化 について
癌診断 について
治療 について
消化器の腫よう について
腫ようの化学・生化学・病理学 について
TGF-β について
受容体 について
メチル化 について
サイレンシング について
食道扁平上皮癌 について
悪性形質転換 について